Publication | Open Access

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II

UrologyMedicineHormonal ReceptorPharmacologyPharmacotherapyAnti-cancer AgentProstatic DiseaseEndocrinologyOncologyBombesin Antagonists Rc-3940-iiEndocrine-related Cancer